During the past decade, Hôpital Civil, Service HTA maladies vasculaires conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Civil, Service HTA maladies vasculaires" are "Hypertension" (2 trials) and "Venous Thromboembolic Disease" (2 trials). Many other conditions were trialed in "Hôpital Civil, Service HTA maladies vasculaires" in a lesser frequency.

Most popular intervention types in "Hôpital Civil, Service HTA maladies vasculaires" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Civil, Service HTA maladies vasculaires" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Civil, Service HTA maladies vasculaires". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hôpital Civil, Service HTA maladies vasculaires, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Civil, Service HTA maladies vasculaires, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".